| The clonal and mutational evolution spectrum of primary triple-negative breast cancers SP Shah, A Roth, R Goya, A Oloumi, G Ha, Y Zhao, G Turashvili, J Ding, ... Nature 486 (7403), 395-399, 2012 | 2268 | 2012 |
| Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept … C Le Tourneau, JP Delord, A Gonçalves, C Gavoille, C Dubot, N Isambert, ... The lancet oncology 16 (13), 1324-1334, 2015 | 1070 | 2015 |
| Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations TF Eleveld, DA Oldridge, V Bernard, J Koster, LC Daage, SJ Diskin, ... Nature genetics 47 (8), 864-871, 2015 | 538 | 2015 |
| DNAJC13 mutations in Parkinson disease C Vilariño-Güell, A Rajput, AJ Milnerwood, B Shah, C Szu-Tu, J Trinh, I Yu, ... Human molecular genetics 23 (7), 1794-1801, 2014 | 351 | 2014 |
| Circulating tumor DNA as a non-invasive substitute to metastasis biopsy for tumor genotyping and personalized medicine in a prospective trial across all tumor types R Lebofsky, C Decraene, V Bernard, M Kamal, A Blin, Q Leroy, TR Frio, ... Molecular oncology 9 (4), 783-790, 2015 | 284 | 2015 |
| NaLi-H1: A universal synthetic library of humanized nanobodies providing highly functional antibodies and intrabodies S Moutel, N Bery, V Bernard, L Keller, E Lemesre, A De Marco, L Ligat, ... Elife 5, e16228, 2016 | 275 | 2016 |
| Circulating tumor DNA changes for early monitoring of anti-PD1 immunotherapy: a proof-of-concept study L Cabel, F Riva, V Servois, A Livartowski, C Daniel, A Rampanou, O Lantz, ... Annals of Oncology 28 (8), 1996-2001, 2017 | 258 | 2017 |
| Emergence of New ALK Mutations at Relapse of Neuroblastoma G Schleiermacher, N Javanmardi, V Bernard, Q Leroy, J Cappo, ... Journal of Clinical Oncology 32 (25), 2727-2734, 2014 | 224 | 2014 |
| Chimeric EWSR1-FLI1 regulates the Ewing sarcoma susceptibility gene EGR2 via a GGAA microsatellite TGP Grünewald, V Bernard, P Gilardi-Hebenstreit, V Raynal, D Surdez, ... Nature genetics 47 (9), 1073-1078, 2015 | 194 | 2015 |
| Circulating tumor DNA and circulating tumor cells in metastatic triple negative breast cancer patients J Madic, A Kiialainen, FC Bidard, F Birzele, G Ramey, Q Leroy, TR Frio, ... International journal of cancer 136 (9), 2158-2165, 2015 | 179 | 2015 |
| Whole-exome sequencing of cell-free DNA reveals temporo-spatial heterogeneity and identifies treatment-resistant clones in neuroblastoma M Chicard, L Colmet-Daage, N Clement, A Danzon, M Bohec, V Bernard, ... Clinical Cancer Research 24 (4), 939-949, 2018 | 138 | 2018 |
| Genomic copy number profiling using circulating free tumor DNA highlights heterogeneity in neuroblastoma M Chicard, S Boyault, L Colmet Daage, W Richer, D Gentien, G Pierron, ... Clinical Cancer Research 22 (22), 5564-5573, 2016 | 114 | 2016 |
| TC-motifs at the TATA-box expected position in plant genes: a novel class of motifs involved in the transcription regulation V Bernard, V Brunaud, A Lecharny BMC genomics 11, 1-15, 2010 | 99 | 2010 |
| Frequent somatic mutation in adult intestinal stem cells drives neoplasia and genetic mosaicism during aging K Siudeja, S Nassari, L Gervais, P Skorski, S Lameiras, D Stolfa, M Zande, ... Cell stem cell 17 (6), 663-674, 2015 | 94 | 2015 |
| Bioinformatics for precision medicine in oncology: principles and application to the SHIVA clinical trial N Servant, J Roméjon, P Gestraud, P La Rosa, G Lucotte, S Lair, ... Frontiers in genetics 5, 152, 2014 | 93 | 2014 |
| PLK1 inhibition exhibits strong anti-tumoral activity in CCND1-driven breast cancer metastases with acquired palbociclib resistance E Montaudon, J Nikitorowicz-Buniak, L Sourd, L Morisset, R El Botty, ... Nature communications 11 (1), 4053, 2020 | 91 | 2020 |
| Detection of tumor ALK status in neuroblastoma patients using peripheral blood V Combaret, I Iacono, A Bellini, S Bréjon, V Bernard, A Marabelle, C Coze, ... Cancer medicine 4 (4), 540-550, 2015 | 91 | 2015 |
| A computed method for noninvasive MRI assessment of pulmonary arterial hypertension E Laffon, C Vallet, V Bernard, M Montaudon, D Ducassou, F Laurent, ... Journal of Applied Physiology 96 (2), 463-468, 2004 | 90 | 2004 |
| The European MAPPYACTS trial: precision medicine program in pediatric and adolescent patients with recurrent malignancies P Berlanga, G Pierron, L Lacroix, M Chicard, T Adam de Beaumais, ... Cancer discovery 12 (5), 1266-1281, 2022 | 80 | 2022 |
| Deep Sequencing Reveals Occurrence of Subclonal ALK Mutations in Neuroblastoma at Diagnosis A Bellini, V Bernard, Q Leroy, T Rio Frio, G Pierron, V Combaret, ... Clinical Cancer Research 21 (21), 4913-4921, 2015 | 78 | 2015 |
